Personalized Medicine Partners
 |
| |
 |
| |
 |
| |
 |
Rx-Dx Scintellix is pleased to announce a partnership with Personalized Medicine Partners to apply Decide-S3 Analytics-TM (and in particular, its Rx-Dx module) in the drug development process. |
For Immediate Release ________________________________________________________________ Contact Information info@scintellix.com 1 919 844 0343 Personalized Medicine Partners and Scintellix Announce a Partnership in the Application of Decision Analytics to Personalized Medicine Business Solutions Raleigh, NC, January 18, 2010. Personalized Medicine Partners (PMP) and Scintellix are pleased to announce a partnership in the application of core decision analytics tools in the personalized medicine sector. Their partnership combines PMP’s broad understanding of the business of personalized medicine with Scintellix’s core analytic capabilities, manifest in its Decide-S3 Analytics™ decision support system. PMP and Scintellix will apply Scintellix’s Rx-Dx™ Module to the optimization of clinical indications as well as to drug and diagnostic commercialization approaches. “We are excited about the unique ability of Decide-S3 Analytics™ to elucidate relationships between factors that form a personalized medicine product approach in an objective, quantitative analytical fashion,” said Michael Stocum, Managing Director of PMP. “We believe these more robust methods will enable development team consensus in companies considering how to proceed with such products, as well as create deeper stakeholder connections to the emerging personalized medicine industry.” Peter C. Johnson, MD, President and CEO of Scintellix said “We are delighted to work with PMP to assist the exciting personalized medicine industry to more rapidly and precisely achieve its goals.” About Personalized Medicine Partners: Personalized Medicine Partners is a business and product development company headquartered in the Research Triangle Park region of North Carolina. PMP is dedicated to increasing the value of therapeutic and diagnostic products, technologies & services through integrated product and business development. PMP is focused on both strategic and tactical activities during the creation of personalized medicine products, facilitating the transition from early development through to commercialization. Learn more at http://www.myrxdx.com. About Scintellix: Scintellix is a decision analytics company headquartered in Raleigh, NC. Scintellix specializes in the application of Decide-S3 Analytics™ to solve complex business problems whose solutions hinge on augmenting and maintaining team cohesion. Scintellix supports both strategic and tactical planning to optimize execution of business goals. Learn more at http://www.scintellix.com. |
